The University of Queensland’s Institute for Molecular Bioscience is a leading global research institute. IMB was established in 2000 as UQ’s first research institute and is the cornerstone of one of the largest bioscience research precincts in Australia.
The Institute’s 500 scientists, support staff and postgraduate students from more than 40 countries are working to improve quality of life for all. IMB has three major divisions and four research centres. IMB’s multidisciplinary research programs focus on advancing medical genomics, drug discovery and biotechnology. By investigating the basis of growth and development at the genetic, molecular, cellular and organ level, our researchers aim to better understand the development processes and pathways involved in human and animal health and disease. They also work to translate these findings into diagnostics, technologies and therapeutics to more effectively prevent, detect and treat disease, and deliver a sustainable future for Australia through initiatives such as clean energy and new agricultural compounds.
IMB is equipped with state-of-the-art research infrastructure including mouse and zebrafish facilities, advanced imaging and microarray platforms, high-throughput sequencing, advanced bioinformatics and proteomics – all of which support the Institute’s leading life sciences research. Details of the research interests of the Institute may be accessed on the Institute’s website at: http://www.imb.uq.edu.au.
The position will conduct research aimed at understanding the regulation of cardiovascular development in genetic loss-of-function mouse models. The successful candidate will perform molecular, histological and biochemical techniques, analysing, transgenic, knockout and CRISPR mouse models.
Applicants should possess a PhD in the area of genetics, biochemistry or development biology or have an equivalent combination of relevant experience and/or education/training. You must have demonstrated research competence molecular biology, evidenced by prominent authorship on papers published in well-regarded, peer-reviewed, international journals. Experience in a biomedical research context is preferred, as is a demonstrable interest in cardiovascular development. Attention to detail in carrying out experimental procedures and careful documentation of experimental work is essential. The successful applicant will also show a high level of communication and interpersonal skills, an ability to work collaboratively with colleagues and willingness to accept communal responsibilities in the laboratory.
This is a full-time, fixed term appointment at Academic Research Level A for 2 years. The remuneration package will be in the range $73,356 – $84,985 p.a., plus employer superannuation contributions of up to 17% (total package will be in the range $85,827 – $99,433 p.a.).
To discuss this role please contact Dr Kelly Smith on +61 7 334 62053 or email@example.com